Beta-2 Microglobulin-Deficient Cells

Patent No. EP2699593 (titled "Beta-2 Microglobulin-Deficient Cells") was filed by University OF Washington Through ITS Center FOR Commercialization on Apr 18, 2012. The application was issued on Nov 4, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEMay 30, 2018MARSHALL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2699593

UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Application Number
EP12720040A
Filing Date
Apr 18, 2012
Status
Patent Maintained As Amended
Oct 2, 2020
Publication Date
Nov 4, 2020